You are here: Industry Insights > trial

News List

Comprehensive tumor profiling promises new therapeutic options for patients with advanced cancer worldpharmanews
May 05, 2019
Comprehensive tumor profiling promises new therapeutic options for patients with advanced cancer.
Report calls into question effectiveness of pyridoxine-doxylamine europeanpharmaceuticalreview
April 30, 2019
Report calls into question effectiveness of pyridoxine-doxylamine.
Report calls into question effectiveness of pyridoxine-doxylamine europeanpharmaceuticalreview
April 30, 2019
Report calls into question effectiveness of pyridoxine-doxylamine.
MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS drugs
April 25, 2019
MediciNova Announces Plans to Move Forward with a Phase 3 Trial of MN-166 (ibudilast) in ALS.
Stem cells to grow new immune system in Crohn’s disease patients europeanpharmaceuticalreview
April 22, 2019
A phase III clinical trial looks to use a patients own stem cells to treat the debilitating disease…
Why are BACE inhibitors failing clinical trials? europeanpharmaceuticalreview
April 19, 2019
Researchers are now looking to identify if BACE1 is involved in adult hippocampal neurogenesis, and responsible for the brains ability to repair itself…
Trial Results Unclear for Benefit of Longer Hemodialysis Sessions drugs
April 19, 2019
Trial Results Unclear for Benefit of Longer Hemodialysis Sessions.
Provention Bio Initiates Phase 3 PROTECT Clinical Trial with PRV-031 (Teplizumab) in Patients with Recent Onset Type 1 Diabetes drugs
April 17, 2019
Provention Bio Initiates Phase 3 PROTECT Clinical Trial with PRV-031 (Teplizumab) in Patients with Recent Onset Type 1 Diabetes.
Clinical trials: Breaking the taboo expressbpd
April 16, 2019
Clinical trials: Breaking the taboo.
Catalent Inaugurates Second Shanghai Facility contractpharma
April 15, 2019
To optimize global and local clinical supply solutions for China.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page